From Harry Johns <[email protected]>
Subject Exciting News: Potential New Alzheimer's Drug Treatment
Date October 29, 2020 3:44 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
President & CEO Update

Alzheimer's Association

This message is sent to all Alzheimer's Association and Alzheimer's
Impact Movement board members, all Alzheimer's Association staff, and
volunteers and supporters of AIM and the Alzheimer's Association.

I want to be sure you know about an important development that all of
your contributions to the Alzheimer's Association have helped
make possible.

As you well know, for decades millions of Americans and their loved
ones have waited for a new, more effective treatment for
Alzheimer's disease to be available. On November 6, a Food and
Drug Administration (FDA) Advisory Committee is meeting to review
clinical trial data for a new drug developed for treating cognitive
and functional decline in early Alzheimer's disease.

Given the devastating toll of this disease and the publicly released
research data, the Alzheimer's Association has submitted a
statement supporting approval to the FDA Advisory Committee, which
will make its recommendation to the FDA.
[link removed]

Whatever the final decision by the FDA, this is an important moment.
We have never before been this close to approval of a drug for
Alzheimer's that could change the progression of the disease,
not just the symptoms.

You can rightly be proud of what you've done to advance the
Alzheimer's Association's world leading research program
- we have played a critical role in every major advancement in
the field. I am personally grateful to you for your relentless
dedication to our work toward a world without Alzheimer's and all
other dementia.

Without you, none of this happens.

I look forward to sharing more news with you about this as it
develops. As always, thank you for everything you do to advance our
mission to make a difference today and tomorrow for all of our
constituents.

Harry Johns Signature

Harry Johns
Chief Executive Officer

CONNECT WITH US

Facebook

Twitter

Pinterest

Blog

[link removed]
[link removed]
[link removed]
[link removed]

Alzheimer's Association

Alzheimer's Association
225 N. Michigan Ave., FL 17, Chicago, IL 60601
800.272.3900 | alz.org
tel:800.272.3900
[link removed]

© 2020 Alzheimer's Association. All rights reserved.
Alzheimer's Association is a not-for-profit 501(c)(3) organization.

Contact Us

|

Privacy Policy

|

Unsubscribe

[link removed]
[link removed]
[link removed]



To unsubscribe from all future email, paste the following URL into your browser:
[link removed]
Screenshot of the email generated on import

Message Analysis